FigsharePub Date : 2019-11-04DOI: 10.1021/acsami.9b15434.s001
Yajun Liu (112906), Rui Dai (7865909), Qiuyu Wei (6710492), Wenzhe Li (815057), Guang Zhu (28483), Hao Chi (1797619), Zhaoming Guo (4707061), Li Wang (15202), Changhao Cui (4707058), Jianqiang Xu (317666), Kun Ma (126624)
{"title":"Dual-FunctionalizednJanus Mesoporous Silica Nanoparticlesnwith Active Targeting and Charge Reversal for Synergistic Tumor-TargetingnTherapy","authors":"Yajun Liu (112906), Rui Dai (7865909), Qiuyu Wei (6710492), Wenzhe Li (815057), Guang Zhu (28483), Hao Chi (1797619), Zhaoming Guo (4707061), Li Wang (15202), Changhao Cui (4707058), Jianqiang Xu (317666), Kun Ma (126624)","doi":"10.1021/acsami.9b15434.s001","DOIUrl":"https://doi.org/10.1021/acsami.9b15434.s001","url":null,"abstract":"Janus nanoparticles with an anisotropic feature concentratednmultiplenproperties on a single carrier, providing synergistic effects. Innthis study, dual-functionalized Janus nanoparticles (HA-JMSN/DOX-DMMA)nwere constructed with a tumor-targeting ligand (hyaluronic acid, HA)nmodified on the one side and a charge reversal group (2,3-dimethylmaleicnanhydride, DMMA) on the other side. The drug release of HA-JMSN/DOX-DMMAnwas positively correlated with the acidity of the environment. Thencytotoxicity and cell uptake of HA-JMSN/DOX-DMMA were superior tonthe isotropous nanoparticles. The endocytosis pathway of HA-JMSN/DOX-DMMAninvolved the clathrin-mediated endocytosis (HA) and the micropinocytosisn(DMMA) at the same time, which indicated that they both participatednin the interaction between nanoparticles and tumor cells. After beingninjected intravenously in mice, the distribution of HA-JMSN/DOX-DMMAnin tumor was enhanced significantly. The antitumor therapy study innvivo showed that HA-JMSN/DOX-DMMA inhibited tumor growth and improvednthe survival rate of tumor-bearing mice effectively. In general, HA-JMSN/DOX-DMMAncould take the synergistic effect of active targeting and charge reversalnto deliver drug in tumor cells and kill them efficiently, which wasna promising antitumor nanodrug.","PeriodicalId":523484,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147916862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}